难治性院外心脏骤停的院内心脏骤停转运、体外心肺复苏及即刻有创评估与治疗对功能性神经结局的影响:一项随机临床试验
该单中心随机临床试验在捷克布拉格纳入256例成人目击性院外心脏骤停(推测心源性、未恢复自主循环),比较早期有创策略(机械按压后心脏骤停转运至心脏中心行ECPR及即刻有创评估治疗)与标准策略(现场继续常规高级生命支持)。主要终点180天神经功能良好生存(CPC 1-2)在两组分别为31.5%与22.0%(OR 1.63,95%CI 0.93-2.85;差异9.5%,95%CI -1.3%至20.1%;P=0.09),未达统计学显著。30天神经恢复(30.6% vs 18.2%,OR 1.99,95%CI 1.11-3.57;P=0.02)及出血(31% vs 15%)在侵入策略组更高。试验因预设无效标准提前终止,作者认为可能样本量不足。
要点
- 难治性院外心脏骤停成人中,早期心脏骤停转运+ECPR+有创评估未显著改善180天神经功能良好生存:侵入策略组31.5% vs 标准策略组22.0%(OR 1.63,95%CI 0.93-2.85;P=0.09)。
- 30天神经恢复(CPC 1-2)侵入策略组30.6% vs 标准策略组18.2%(OR 1.99,95%CI 1.11-3.57;P=0.02),差异12.4%(95%CI 1.9%至22.7%)。
- 30天心脏恢复侵入策略组43.5% vs 标准策略组34.1%(OR 1.49,95%CI 0.91-2.47;P=0.12),未达统计学显著。
- 出血侵入策略组31% vs 标准策略组15%,侵入策略组更常见。
- 试验因预设无效标准提前终止,作者认为可能样本量不足以检出临床相关差异。
适用人群与场景
- 成人目击性院外心脏骤停,推测心源性,未恢复自主循环(难治性院外心脏骤停)。
- 单中心随机临床试验,在捷克布拉格进行,纳入256例(计划样本量285例),2013年3月至2020年10月入组,随访至死亡或第180天(末例随访截至2021年3月30日)。
处置流程与药物剂量
- 侵入策略组(n=124):开始机械按压,随后心脏骤停期间转运至心脏中心行ECPR及即刻有创评估与治疗。
- 标准策略组(n=132):现场继续常规高级生命支持。
研究设计与关键结果
- 设计:单中心随机临床试验,256例成人目击性院外心脏骤停(推测心源性、未恢复自主循环),侵入策略组124例 vs 标准策略组132例;中位年龄58岁,女性44例(17%);256例(100%)完成试验。
- 主要终点180天神经功能良好生存(CPC 1-2):侵入策略组39例(31.5%)vs 标准策略组29例(22.0%),OR 1.63(95%CI 0.93-2.85),差异9.5%(95%CI -1.3%至20.1%),P=0.09。
- 30天神经恢复(30天内任意时点CPC 1-2):侵入策略组38例(30.6%)vs 标准策略组24例(18.2%),OR 1.99(95%CI 1.11-3.57),差异12.4%(95%CI 1.9%至22.7%),P=0.02。
- 30天心脏恢复(至少24小时无需药物或机械心脏支持):侵入策略组54例(43.5%)vs 标准策略组45例(34.1%),OR 1.49(95%CI 0.91-2.47),差异9.4%(95%CI -2.5%至21%),P=0.12。
- 不良事件:出血侵入策略组31% vs 标准策略组15%。
- 试验因预设无效标准达到,经数据与安全监察委员会建议提前终止。
证据类型、等级与局限
- 证据类型:单中心随机临床试验(RCT),ClinicalTrials.gov注册号NCT01511666。
- 试验因预设无效标准达到而提前终止。
- 局限:作者指出试验可能样本量不足以检出临床相关差异(possibly underpowered)。
对床旁实践的改变
- 对难治性院外心脏骤停成人,早期心脏骤停转运、ECPR及即刻有创评估与治疗这一组合策略,与标准复苏相比未显著改善180天神经功能良好生存(31.5% vs 22.0%,P=0.09)。
- 侵入策略组30天神经恢复比例更高(30.6% vs 18.2%,P=0.02),但出血更常见(31% vs 15%)。
- 作者认为该试验可能样本量不足,不足以检出临床相关差异。
指南或共识出处
- ClinicalTrials.gov Identifier: NCT01511666
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Out-of-hospital cardiac arrest (OHCA) has poor outcome. Whether intra-arrest transport, extracorporeal cardiopulmonary resuscitation (ECPR), and immediate invasive assessment and treatment (invasive strategy) is beneficial in this setting remains uncertain.
OBJECTIVE: To determine whether an early invasive approach in adults with refractory OHCA improves neurologically favorable survival.
DESIGN, SETTING, AND PARTICIPANTS: Single-center, randomized clinical trial in Prague, Czech Republic, of adults with a witnessed OHCA of presumed cardiac origin without return of spontaneous circulation. A total of 256 participants, of a planned sample size of 285, were enrolled between March 2013 and October 2020. Patients were observed until death or day 180 (last patient follow-up ended on March 30, 2021).
INTERVENTIONS: In the invasive strategy group (n = 124), mechanical compression was initiated, followed by intra-arrest transport to a cardiac center for ECPR and immediate invasive assessment and treatment. Regular advanced cardiac life support was continued on-site in the standard strategy group (n = 132).
MAIN OUTCOMES AND MEASURES: The primary outcome was survival with a good neurologic outcome (defined as Cerebral Performance Category [CPC] 1-2) at 180 days after randomization. Secondary outcomes included neurologic recovery at 30 days (defined as CPC 1-2 at any time within the first 30 days) and cardiac recovery at 30 days (defined as no need for pharmacological or mechanical cardiac support for at least 24 hours).
RESULTS: The trial was stopped at the recommendation of the data and safety monitoring board when prespecified criteria for futility were met. Among 256 patients (median age, 58 years; 44 [17%] women), 256 (100%) completed the trial. In the main analysis, 39 patients (31.5%) in the invasive strategy group and 29 (22.0%) in the standard strategy group survived to 180 days with good neurologic outcome (odds ratio [OR], 1.63 [95% CI, 0.93 to 2.85]; difference, 9.5% [95% CI, -1.3% to 20.1%]; P = .09). At 30 days, neurologic recovery had occurred in 38 patients (30.6%) in the invasive strategy group and in 24 (18.2%) in the standard strategy group (OR, 1.99 [95% CI, 1.11 to 3.57]; difference, 12.4% [95% CI, 1.9% to 22.7%]; P = .02), and cardiac recovery had occurred in 54 (43.5%) and 45 (34.1%) patients, respectively (OR, 1.49 [95% CI, 0.91 to 2.47]; difference, 9.4% [95% CI, -2.5% to 21%]; P = .12). Bleeding occurred more frequently in the invasive strategy vs standard strategy group (31% vs 15%, respectively).
CONCLUSIONS AND RELEVANCE: Among patients with refractory out-of-hospital cardiac arrest, the bundle of early intra-arrest transport, ECPR, and invasive assessment and treatment did not significantly improve survival with neurologically favorable outcome at 180 days compared with standard resuscitation. However, the trial was possibly underpowered to detect a clinically relevant difference.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01511666.
参考来源
- Belohlavek J, Smalcova J, Rob D, et al. Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2022. PMID: 35191923. doi:10.1001/jama.2022.1025
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。